Can data from paediatric cohorts solve the COVID-19 puzzle?
Open Access
- 1 September 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 16 (9), e1008798
- https://doi.org/10.1371/journal.ppat.1008798
Abstract
COVID-19, caused by SARS-CoV-2, is significantly more severe in adults than in children. The biological reasons for this difference remain to be elucidated. We have compared the most recent virological and immunological data related to COVID-19 between adults and children and contrasted this with earlier data from severe acute respiratory syndrome (SARS) caused by the related SARS-CoV-1 in 2003. Based on these available data, a number of hypotheses are proposed to explain the difference in COVID-19 clinical outcomes between adults and children. NF-kB may be a key factor that could explain the severe clinical manifestations of COVID-19 in adults as well as rare complications associated with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in paediatric COVID-19 patients.This publication has 88 references indexed in Scilit:
- Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κBVirology, 2007
- Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike VariantsPLoS Medicine, 2006
- Children's vaccines do not induce cross reactivity against SARS-CoVJournal of Clinical Pathology, 2006
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- Neutralizing Antibody Response and SARS SeverityEmerging Infectious Diseases, 2005
- Lack of Association between New Haven Coronavirus and Kawasaki DiseaseThe Journal of Infectious Diseases, 2005
- Severe acute respiratory syndrome (SARS) in neonates and childrenArchives of Disease in Childhood: Fetal & Neonatal, 2005
- Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3Journal of Virology, 2005
- Association between a Novel Human Coronavirus and Kawasaki DiseaseThe Journal of Infectious Diseases, 2005
- Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionThe Journal of Infectious Diseases, 2004